Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MNKD)

MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update

GlobeNewswire November 7, 2024

MannKind to Present at 2024 UBS Healthcare Conference

GlobeNewswire November 5, 2024

MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases

GlobeNewswire November 4, 2024

MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

GlobeNewswire October 31, 2024

More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)

GlobeNewswire September 30, 2024

MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

GlobeNewswire September 18, 2024

MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 10, 2024

MannKind to Present at Upcoming Conferences

GlobeNewswire August 27, 2024

Kent Kresa to Retire from MannKind's Board of Directors; Steven B. Binder to be Appointed to the Board

GlobeNewswire August 14, 2024
View More News ››

Opinion & Analysis (NDAQ:MNKD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MNKD)

MannKind Corporation (MNKD): A Promising Future in Inhaled T

http://beyondspx.com/2024/07/31/mannkind-corporation-mnkd-a-promising-future-in-inhaled-therapeutics/
MikeTester - August 2, 2024

slow & steady for this one

climbing up ,so glta .
coolfooldumbguy - January 15, 2019

it's a buy today for me

it looks like a turnaround situation,so glta.
coolfooldumbguy - January 14, 2019

FINANCIALS ARE OUT

https://www.nasdaq.com/press-release/mannkind-corporation-reports-2018-third-quarter-financial-results-20181101-00761
Interpolation2 - November 1, 2018

RE:RE:RE:Chart is looking explosive

Well, I bought back in Friday. Stock looks ripe again. I think we are in for good times again, soon. Ando
ando - September 30, 2018

RE:RE:Chart is looking explosive

At the time I wrote that they stock was somewhere around 1.50. It went above 6.00 in a couple months so I don't think that is too bad...
ando - August 6, 2018
View more Bullboard ››

LQWD Technologies Corp.

LQWD Technologies Corp.

LQWD Technologies Corp. is a Canada-based Bitcoin lightning network company. The Company is the provider of enterprise-grade ...
View More »